LC
GILD icon

Lawood & Co’s Gilead Sciences GILD Stock Holding History

Lawood & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$731K Buy
5,784
+370
+7% +$48.8K 0.49% 44
2026
Q1 		$755K Buy
5,414
+260
+5% +$36.4K 0.7% 42
2025
Q4 		$633K Buy
+5,154
New +$626K 0.6% 46

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lawood & Co's GILD Position: Q2 2026 in Review

Lawood & Co increased its Gilead Sciences (GILD) stake by 6.8% in Q2 2026, buying an estimated $48.8K and bringing the position to 5,784 shares worth $731K. The position accounts for 0.49% of the portfolio, ranked #44.

Lawood & Co first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $755K in Q1 2026. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Lawood & Co held 5,784 shares of Gilead Sciences worth $731K as of Q2 2026.
  • Lawood & Co bought 370 Gilead Sciences shares in Q2 2026, an estimated $48.8K.
  • Gilead Sciences made up 0.49% of Lawood & Co's portfolio in Q2 2026, its #44 holding.
  • Lawood & Co first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Lawood & Co's Gilead Sciences position peaked at $755K in Q1 2026.
  • 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Lawood & Co's 13F filing for Q2 2026, filed 13 Jul 2026.